Group One Trading
DWTX

Group One Trading’s Dogwood Therapeutics DWTX Stock Holding History

Group One Trading’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-148
Closed -$5.11K – 8430
2023
Q2 		$5.11K Buy
+148
New +$4.22K ﹤0.01% 6705

Other funds holding DWTX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

Group One Trading's DWTX Position: Q1 2026 in Review

Group One Trading held its Dogwood Therapeutics (DWTX) position steady in Q1 2026 at 9 shares worth $19. The position accounts for ﹤0.01% of the portfolio, ranked #7464.

Group One Trading first reported a position in DWTX in Q3 2022 and has held it in 15 quarters since. The position peaked at $22.9K in Q2 2023. 13 funds tracked by Wall St. Rank hold DWTX as of Q1 2026.

  • Group One Trading held 9 shares of Dogwood Therapeutics worth $19 as of Q1 2026.
  • Group One Trading left its Dogwood Therapeutics share count unchanged in Q1 2026.
  • Dogwood Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7464 holding.
  • Group One Trading first reported a position in Dogwood Therapeutics in Q3 2022 and has held it in 15 quarters since.
  • Group One Trading's Dogwood Therapeutics position peaked at $22.9K in Q2 2023.
  • 13 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.